InfuSystem Holdings (INFU) Change in Receivables (2010 - 2026)
InfuSystem Holdings' (INFU) quarterly Change in Receivables came in at $2.2 million in Q1 2026, up 7.4% YoY from $2.1 million in Q1 2025, and up 192.59% on a QoQ basis from -$2.4 million in Q4 2025.
InfuSystem Holdings (INFU) Change in Receivables (2010 - 2026) Analysis & Trends
InfuSystem Holdings (INFU) has 11 years of Change in Receivables data on file, last reported at $2.2 million in Q1 2026.
- Quarterly Change in Receivables rose 7.4% year-over-year to $2.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$108000.0 (down 104.22% YoY) and the FY2025 annual result came in at -$263000.0, down 137.52% from the prior year.
- Change in Receivables rose to $2.2 million in Q1 2026, from -$2.4 million in the prior quarter.
- In the past five years, Change in Receivables ranged from a high of $2.2 million in Q1 2026 to a low of -$2.4 million in Q4 2025.
- A 5-year average of $364941.2 and a median of $237000.0 in 2024 frame the typical range for Change in Receivables.
- Annual changes were most pronounced in 2022 — Change in Receivables plunged 289.01% — and 2025, when it soared 783.97%.
- Tracing INFU's Change in Receivables over 5 years: stood at $546000.0 in 2022, then jumped by 143.22% to $1.3 million in 2023, then slumped by 148.72% to -$647000.0 in 2024, then sank by 275.58% to -$2.4 million in 2025, then jumped by 192.59% to $2.2 million in 2026.
- The last three Change in Receivables figures came in at $2.2 million (Q1 2026), -$2.4 million (Q4 2025), and $78000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | 386.00 Mn |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | 177.00 Mn |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | 287.00 Mn |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | 46.00 Mn |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | 10.20 Mn |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | 172.10 Mn |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | 79.00 Mn |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | - |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | -90.00 Mn |
| 10 | InfuSystem Holdings | 244.87 Mn | 243.90 Mn | 21.41 Mn | 3.44 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 3.44 Mn |
| Jun 30, 2026 | 3.44 Mn |
| Mar 31, 2026 | 2.25 Mn |
| Mar 31, 2026 | 2.25 Mn |
| Dec 31, 2025 | -2.43 Mn |
| Dec 31, 2025 | -2.43 Mn |
| Sep 30, 2025 | 78,000.00 |
| Sep 30, 2025 | 78,000.00 |
| Jun 30, 2025 | -6,000.00 |
| Jun 30, 2025 | -6,000.00 |
| Mar 31, 2025 | 2.10 Mn |
| Mar 31, 2025 | 2.10 Mn |
| Dec 31, 2024 | -647,000.00 |
| Dec 31, 2024 | -647,000.00 |
| Sep 30, 2024 | 145,000.00 |
| Sep 30, 2024 | 145,000.00 |
| Jun 30, 2024 | 966,000.00 |
| Jun 30, 2024 | 966,000.00 |
| Mar 31, 2024 | 237,000.00 |
| Mar 31, 2024 | 237,000.00 |